Apellis Pharmaceuticals, Inc.
APLS
Transaktioner
1000
Köp
297
Sälj
703
Nettoinsynsflöde
-159.6 mn USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
1000 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2026-05-14 | Baumal Caroline | Chief Medical Officer | Sell | 87 k | – | – |
| 2026-05-14 | Baumal Caroline | Chief Medical Officer | Buy | 41 k | – | – |
| 2026-05-14 | Baumal Caroline | Chief Medical Officer | Sell | 41 k | – | – |
| 2026-05-14 | Baumal Caroline | Chief Medical Officer | Buy | 26 k | – | – |
| 2026-05-14 | Baumal Caroline | Chief Medical Officer | Sell | 26 k | – | – |
| 2026-05-14 | Baumal Caroline | Chief Medical Officer | Sell | 9 k | – | – |
| 2026-05-14 | Baumal Caroline | Chief Medical Officer | Sell | 13 k | – | – |
| 2026-05-14 | Baumal Caroline | Chief Medical Officer | Sell | 30 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 426 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 373 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 472 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 300 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 234 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Buy | 144 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 144 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Buy | 87 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 87 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Buy | 98 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 98 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Buy | 196 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 196 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 21 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 36 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 98 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 196 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 145 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 10 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 50 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Buy | 41 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 41 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Buy | 29 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 29 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Buy | 28 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 28 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Buy | 56 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 56 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 32 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 56 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 12 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 6 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 7 k | – | – |
| 2026-05-14 | WHEELER CRAIG A | Director | Sell | 24 k | – | – |
| 2026-05-14 | WHEELER CRAIG A | Director | Sell | 15 k | – | – |
| 2026-05-14 | WHEELER CRAIG A | Director | Sell | 8 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Sell | 128 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Buy | 15 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Sell | 15 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Buy | 30 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Sell | 30 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Sell | 22 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Sell | 45 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Sell | 30 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Sell | 30 k | – | – |
| 2026-05-14 | O'Brien Stephanie Monaghan | Director | Sell | 26 k | – | – |
| 2026-05-14 | O'Brien Stephanie Monaghan | Director | Sell | 6 k | – | – |
| 2026-05-14 | O'Brien Stephanie Monaghan | Director | Sell | 3 k | – | – |
| 2026-05-14 | O'Brien Stephanie Monaghan | Director | Sell | 6 k | – | – |
| 2026-05-14 | O'Brien Stephanie Monaghan | Director | Sell | 8 k | – | – |
| 2026-05-14 | O'Brien Stephanie Monaghan | Director | Sell | 4 k | – | – |
| 2026-05-14 | O'Brien Stephanie Monaghan | Director | Sell | 4 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 115 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Buy | 41 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 41 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Buy | 19 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 19 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Buy | 37 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 37 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Buy | 18 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 18 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 37 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 5 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 8 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 21 k | – | – |
| 2026-05-14 | Walbert Keli | Director | Sell | 17 k | – | – |
| 2026-05-14 | Walbert Keli | Director | Sell | 8 k | – | – |
| 2026-05-14 | Walbert Keli | Director | Sell | 664 | – | – |
| 2026-05-14 | Walbert Keli | Director | Sell | 7 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 116 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Buy | 23 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 23 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Buy | 45 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 45 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Buy | 24 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 24 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Buy | 41 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 41 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 6 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 10 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 27 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 45 k | – | – |
| 2026-05-14 | Chan Gerald | Director | Sell | 26 k | – | – |
| 2026-05-14 | Chan Gerald | Director | Sell | 3 k | – | – |
| 2026-05-14 | Chan Gerald | Director | Sell | 6 k | – | – |
| 2026-05-14 | Chan Gerald | Director | Sell | 8 k | – | – |
| 2026-05-14 | Chan Gerald | Director | Sell | 4 k | – | – |
| 2026-05-14 | Chan Gerald | Director | Sell | 4 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 1.2 mn | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Buy | 41 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 41 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Buy | 10 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 10 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Buy | 13 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 13 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Buy | 26 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 26 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 5 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 3 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 11 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 26 k | – | – |
| 2026-05-14 | Machiels Alec | Director | Sell | 385 k | – | – |
| 2026-05-14 | Machiels Alec | Director | Sell | 250 k | – | – |
| 2026-05-14 | Machiels Alec | Director | Sell | 12 k | – | – |
| 2026-05-14 | Machiels Alec | Director | Sell | 150 k | – | – |
| 2026-05-14 | Machiels Alec | Director | Sell | 3 k | – | – |
| 2026-05-14 | Machiels Alec | Director | Sell | 6 k | – | – |
| 2026-05-14 | Machiels Alec | Director | Sell | 8 k | – | – |
| 2026-05-14 | Machiels Alec | Director | Sell | 4 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 141 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 71 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 41 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 41 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 31 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 31 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 29 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 29 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 58 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 58 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 7 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 12 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 34 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 58 k | – | – |
| 2026-05-14 | FONTEYNE PAUL R. | Director | Sell | 31 k | – | – |
| 2026-05-14 | FONTEYNE PAUL R. | Director | Sell | 3 k | – | – |
| 2026-05-14 | FONTEYNE PAUL R. | Director | Sell | 6 k | – | – |
| 2026-05-14 | FONTEYNE PAUL R. | Director | Sell | 8 k | – | – |
| 2026-05-14 | FONTEYNE PAUL R. | Director | Sell | 4 k | – | – |
| 2026-05-14 | FONTEYNE PAUL R. | Director | Sell | 4 k | – | – |
| 2026-05-14 | MELTZER LESLIE | Chief Research and Development | Sell | 107 k | – | – |
| 2026-05-14 | MELTZER LESLIE | Chief Research and Development | Buy | 23 k | – | – |
| 2026-05-14 | MELTZER LESLIE | Chief Research and Development | Sell | 23 k | – | – |
| 2026-05-14 | MELTZER LESLIE | Chief Research and Development | Buy | 45 k | – | – |
| 2026-05-14 | MELTZER LESLIE | Chief Research and Development | Sell | 45 k | – | – |
| 2026-05-14 | MELTZER LESLIE | Chief Research and Development | Sell | 62 k | – | – |
| 2026-05-14 | MELTZER LESLIE | Chief Research and Development | Sell | 45 k | – | – |
| 2026-05-14 | Dolsten Mikael | Director | Sell | 14 k | – | – |
| 2026-05-14 | Dolsten Mikael | Director | Sell | 14 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 66 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Buy | 6 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 6 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Buy | 8 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 8 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Buy | 16 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 16 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Buy | 8 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 8 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 2 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 4 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 9 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 16 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 6 k | – | – |
| 2026-05-14 | Dunlop A. Sinclair | Director | Sell | 162 k | – | – |
| 2026-05-14 | Dunlop A. Sinclair | Director | Sell | 3 k | – | – |
| 2026-05-14 | Dunlop A. Sinclair | Director | Sell | 6 k | – | – |
| 2026-05-14 | Dunlop A. Sinclair | Director | Sell | 8 k | – | – |
| 2026-05-14 | Dunlop A. Sinclair | Director | Sell | 4 k | – | – |
| 2026-05-14 | Baumal Caroline | Chief Medical Officer | Sell | 87 k | – | – |
| 2026-05-14 | Baumal Caroline | Chief Medical Officer | Buy | 41 k | – | – |
| 2026-05-14 | Baumal Caroline | Chief Medical Officer | Sell | 41 k | – | – |
| 2026-05-14 | Baumal Caroline | Chief Medical Officer | Buy | 26 k | – | – |
| 2026-05-14 | Baumal Caroline | Chief Medical Officer | Sell | 26 k | – | – |
| 2026-05-14 | Baumal Caroline | Chief Medical Officer | Sell | 9 k | – | – |
| 2026-05-14 | Baumal Caroline | Chief Medical Officer | Sell | 13 k | – | – |
| 2026-05-14 | Baumal Caroline | Chief Medical Officer | Sell | 30 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Sell | 128 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Buy | 15 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Sell | 15 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Buy | 30 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Sell | 30 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Sell | 22 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Sell | 45 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Sell | 30 k | – | – |
| 2026-05-14 | Boucher Kelley | Chief People Officer | Sell | 30 k | – | – |
| 2026-05-14 | Chan Gerald | Director | Sell | 26 k | – | – |
| 2026-05-14 | Chan Gerald | Director | Sell | 3 k | – | – |
| 2026-05-14 | Chan Gerald | Director | Sell | 6 k | – | – |
| 2026-05-14 | Chan Gerald | Director | Sell | 8 k | – | – |
| 2026-05-14 | Chan Gerald | Director | Sell | 4 k | – | – |
| 2026-05-14 | Chan Gerald | Director | Sell | 4 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 66 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Buy | 6 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 6 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Buy | 8 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 8 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Buy | 16 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 16 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Buy | 8 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 8 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 2 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 4 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 9 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 16 k | – | – |
| 2026-05-14 | Chopas James George | VP/Chief Accounting Officer | Sell | 6 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 115 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Buy | 41 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 41 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Buy | 19 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 19 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Buy | 37 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 37 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Buy | 18 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 18 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 37 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 5 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 8 k | – | – |
| 2026-05-14 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 21 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 1.2 mn | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Buy | 41 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 41 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Buy | 10 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 10 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Buy | 13 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 13 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Buy | 26 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 26 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 5 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 3 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 11 k | – | – |
| 2026-05-14 | Deschatelets Pascal | Chief Scientific Officer | Sell | 26 k | – | – |
| 2026-05-14 | Dolsten Mikael | Director | Sell | 14 k | – | – |
| 2026-05-14 | Dolsten Mikael | Director | Sell | 14 k | – | – |
| 2026-05-14 | Dunlop A. Sinclair | Director | Sell | 162 k | – | – |
| 2026-05-14 | Dunlop A. Sinclair | Director | Sell | 3 k | – | – |
| 2026-05-14 | Dunlop A. Sinclair | Director | Sell | 6 k | – | – |
| 2026-05-14 | Dunlop A. Sinclair | Director | Sell | 8 k | – | – |
| 2026-05-14 | Dunlop A. Sinclair | Director | Sell | 4 k | – | – |
| 2026-05-14 | FONTEYNE PAUL R. | Director | Sell | 31 k | – | – |
| 2026-05-14 | FONTEYNE PAUL R. | Director | Sell | 3 k | – | – |
| 2026-05-14 | FONTEYNE PAUL R. | Director | Sell | 6 k | – | – |
| 2026-05-14 | FONTEYNE PAUL R. | Director | Sell | 8 k | – | – |
| 2026-05-14 | FONTEYNE PAUL R. | Director | Sell | 4 k | – | – |
| 2026-05-14 | FONTEYNE PAUL R. | Director | Sell | 4 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 426 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 373 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 472 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 300 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 234 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Buy | 144 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 144 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Buy | 87 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 87 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Buy | 98 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 98 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Buy | 196 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 196 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 21 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 36 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 98 k | – | – |
| 2026-05-14 | Francois Cedric | Chief Executive Officer | Sell | 196 k | – | – |
| 2026-05-14 | MELTZER LESLIE | Chief Research and Development | Sell | 107 k | – | – |
| 2026-05-14 | MELTZER LESLIE | Chief Research and Development | Buy | 23 k | – | – |
| 2026-05-14 | MELTZER LESLIE | Chief Research and Development | Sell | 23 k | – | – |
| 2026-05-14 | MELTZER LESLIE | Chief Research and Development | Buy | 45 k | – | – |
| 2026-05-14 | MELTZER LESLIE | Chief Research and Development | Sell | 45 k | – | – |
| 2026-05-14 | MELTZER LESLIE | Chief Research and Development | Sell | 62 k | – | – |
| 2026-05-14 | MELTZER LESLIE | Chief Research and Development | Sell | 45 k | – | – |
| 2026-05-14 | Machiels Alec | Director | Sell | 385 k | – | – |
| 2026-05-14 | Machiels Alec | Director | Sell | 250 k | – | – |
| 2026-05-14 | Machiels Alec | Director | Sell | 12 k | – | – |
| 2026-05-14 | Machiels Alec | Director | Sell | 150 k | – | – |
| 2026-05-14 | Machiels Alec | Director | Sell | 3 k | – | – |
| 2026-05-14 | Machiels Alec | Director | Sell | 6 k | – | – |
| 2026-05-14 | Machiels Alec | Director | Sell | 8 k | – | – |
| 2026-05-14 | Machiels Alec | Director | Sell | 4 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 116 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Buy | 23 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 23 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Buy | 45 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 45 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Buy | 24 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 24 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Buy | 41 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 41 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 6 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 10 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 27 k | – | – |
| 2026-05-14 | Nicholson Nur | Chief Technical Officer | Sell | 45 k | – | – |
| 2026-05-14 | O'Brien Stephanie Monaghan | Director | Sell | 26 k | – | – |
| 2026-05-14 | O'Brien Stephanie Monaghan | Director | Sell | 6 k | – | – |
| 2026-05-14 | O'Brien Stephanie Monaghan | Director | Sell | 3 k | – | – |
| 2026-05-14 | O'Brien Stephanie Monaghan | Director | Sell | 6 k | – | – |
| 2026-05-14 | O'Brien Stephanie Monaghan | Director | Sell | 8 k | – | – |
| 2026-05-14 | O'Brien Stephanie Monaghan | Director | Sell | 4 k | – | – |
| 2026-05-14 | O'Brien Stephanie Monaghan | Director | Sell | 4 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 141 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 71 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 41 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 41 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 31 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 31 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 29 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 29 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 58 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 58 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 7 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 12 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 34 k | – | – |
| 2026-05-14 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 58 k | – | – |
| 2026-05-14 | WHEELER CRAIG A | Director | Sell | 24 k | – | – |
| 2026-05-14 | WHEELER CRAIG A | Director | Sell | 15 k | – | – |
| 2026-05-14 | WHEELER CRAIG A | Director | Sell | 8 k | – | – |
| 2026-05-14 | Walbert Keli | Director | Sell | 17 k | – | – |
| 2026-05-14 | Walbert Keli | Director | Sell | 8 k | – | – |
| 2026-05-14 | Walbert Keli | Director | Sell | 664 | – | – |
| 2026-05-14 | Walbert Keli | Director | Sell | 7 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 145 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 10 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 50 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Buy | 41 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 41 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Buy | 29 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 29 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Buy | 28 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 28 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Buy | 56 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 56 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 32 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 56 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 12 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 6 k | – | – |
| 2026-05-14 | Watson David O. | General Counsel | Sell | 7 k | – | – |
| 2026-04-29 | Baumal Caroline | Chief Medical Officer | Sell | 900 | 0,00 | 0 USD |
| 2026-04-29 | Baumal Caroline | Chief Medical Officer | Sell | 900 | 0,00 | 0 USD |
| 2026-04-17 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 11 k | 0,00 | 0 USD |
| 2026-04-17 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 11 k | 0,00 | 0 USD |
| 2026-04-17 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 11 k | 0,00 | 0 USD |
| 2026-04-17 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 11 k | 0,00 | 0 USD |
| 2026-04-06 | O'Brien Stephanie Monaghan | Director | Buy | 6 k | 0,00 | 0 USD |
| 2026-04-06 | O'Brien Stephanie Monaghan | Director | Buy | 6 k | 0,00 | 0 USD |
| 2026-03-11 | Francois Cedric | Chief Executive Officer | Sell | 65 k | 0,00 | 0 USD |
| 2026-03-11 | Francois Cedric | Chief Executive Officer | Buy | 65 k | 0,00 | 0 USD |
| 2026-03-11 | Francois Cedric | Chief Executive Officer | Sell | 65 k | 0,00 | 0 USD |
| 2026-03-11 | Francois Cedric | Chief Executive Officer | Buy | 65 k | 0,00 | 0 USD |
| 2026-02-27 | Dolsten Mikael | Director | Buy | 14 k | 0,00 | 0 USD |
| 2026-02-27 | Dolsten Mikael | Director | Buy | 14 k | 0,00 | 0 USD |
| 2026-02-11 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 368 | 22,15 | 8 k USD |
| 2026-02-11 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 368 | 22,15 | 8 k USD |
| 2026-02-03 | Francois Cedric | Chief Executive Officer | Buy | 9 k | 3,76 | 33 k USD |
| 2026-02-03 | Francois Cedric | Chief Executive Officer | Buy | 9 k | 3,76 | 33 k USD |
| 2026-01-28 | Francois Cedric | Chief Executive Officer | Buy | 196 k | 0,00 | 0 USD |
| 2026-01-28 | Watson David O. | General Counsel | Buy | 56 k | 0,00 | 0 USD |
| 2026-01-28 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 58 k | 0,00 | 0 USD |
| 2026-01-28 | Nicholson Nur | Chief Technical Officer | Buy | 45 k | 0,00 | 0 USD |
| 2026-01-28 | MELTZER LESLIE | Chief Research and Development | Buy | 45 k | 0,00 | 0 USD |
| 2026-01-28 | Deschatelets Pascal | Chief Scientific Officer | Buy | 26 k | 0,00 | 0 USD |
| 2026-01-28 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Buy | 37 k | 0,00 | 0 USD |
| 2026-01-28 | Chopas James George | VP/Chief Accounting Officer | Buy | 16 k | 0,00 | 0 USD |
| 2026-01-28 | Boucher Kelley | Chief People Officer | Buy | 30 k | 0,00 | 0 USD |
| 2026-01-28 | Boucher Kelley | Chief People Officer | Buy | 30 k | 0,00 | 0 USD |
| 2026-01-28 | Chopas James George | VP/Chief Accounting Officer | Buy | 16 k | 0,00 | 0 USD |
| 2026-01-28 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Buy | 37 k | 0,00 | 0 USD |
| 2026-01-28 | Deschatelets Pascal | Chief Scientific Officer | Buy | 26 k | 0,00 | 0 USD |
| 2026-01-28 | Francois Cedric | Chief Executive Officer | Buy | 196 k | 0,00 | 0 USD |
| 2026-01-28 | MELTZER LESLIE | Chief Research and Development | Buy | 45 k | 0,00 | 0 USD |
| 2026-01-28 | Nicholson Nur | Chief Technical Officer | Buy | 45 k | 0,00 | 0 USD |
| 2026-01-28 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 58 k | 0,00 | 0 USD |
| 2026-01-28 | Watson David O. | General Counsel | Buy | 56 k | 0,00 | 0 USD |
| 2026-01-22 | Watson David O. | General Counsel | Sell | 8 k | 21,77 | 170 k USD |
| 2026-01-22 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 10 k | 21,77 | 224 k USD |
| 2026-01-22 | Nicholson Nur | Chief Technical Officer | Sell | 8 k | 21,77 | 168 k USD |
| 2026-01-22 | Francois Cedric | Chief Executive Officer | Sell | 27 k | 21,77 | 592 k USD |
| 2026-01-22 | Deschatelets Pascal | Chief Scientific Officer | Sell | 6 k | 21,77 | 129 k USD |
| 2026-01-22 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 3 k | 21,77 | 73 k USD |
| 2026-01-22 | Chopas James George | VP/Chief Accounting Officer | Sell | 2 k | 21,77 | 45 k USD |
| 2026-01-22 | Baumal Caroline | Chief Medical Officer | Sell | 3 k | 21,77 | 61 k USD |
| 2026-01-22 | Baumal Caroline | Chief Medical Officer | Sell | 3 k | 21,77 | 61 k USD |
| 2026-01-22 | Chopas James George | VP/Chief Accounting Officer | Sell | 2 k | 21,77 | 45 k USD |
| 2026-01-22 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 3 k | 21,77 | 73 k USD |
| 2026-01-22 | Deschatelets Pascal | Chief Scientific Officer | Sell | 6 k | 21,77 | 129 k USD |
| 2026-01-22 | Francois Cedric | Chief Executive Officer | Sell | 27 k | 21,77 | 592 k USD |
| 2026-01-22 | Nicholson Nur | Chief Technical Officer | Sell | 8 k | 21,77 | 168 k USD |
| 2026-01-22 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 10 k | 21,77 | 224 k USD |
| 2026-01-22 | Watson David O. | General Counsel | Sell | 8 k | 21,77 | 170 k USD |
| 2026-01-20 | Watson David O. | General Counsel | Sell | 2 k | 19,79 | 49 k USD |
| 2026-01-20 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 3 k | 19,79 | 57 k USD |
| 2026-01-20 | Nicholson Nur | Chief Technical Officer | Sell | 2 k | 19,79 | 44 k USD |
| 2026-01-20 | Francois Cedric | Chief Executive Officer | Sell | 8 k | 19,79 | 162 k USD |
| 2026-01-20 | Deschatelets Pascal | Chief Scientific Officer | Sell | 909 | 19,79 | 18 k USD |
| 2026-01-20 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 1 k | 19,79 | 26 k USD |
| 2026-01-20 | Chopas James George | VP/Chief Accounting Officer | Sell | 726 | 19,79 | 14 k USD |
| 2026-01-20 | Baumal Caroline | Chief Medical Officer | Sell | 2 k | 19,79 | 37 k USD |
| 2026-01-20 | Baumal Caroline | Chief Medical Officer | Sell | 2 k | 19,79 | 37 k USD |
| 2026-01-20 | Chopas James George | VP/Chief Accounting Officer | Sell | 726 | 19,79 | 14 k USD |
| 2026-01-20 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 1 k | 19,79 | 26 k USD |
| 2026-01-20 | Deschatelets Pascal | Chief Scientific Officer | Sell | 909 | 19,79 | 18 k USD |
| 2026-01-20 | Francois Cedric | Chief Executive Officer | Sell | 8 k | 19,79 | 162 k USD |
| 2026-01-20 | Nicholson Nur | Chief Technical Officer | Sell | 2 k | 19,79 | 44 k USD |
| 2026-01-20 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 3 k | 19,79 | 57 k USD |
| 2026-01-20 | Watson David O. | General Counsel | Sell | 2 k | 19,79 | 49 k USD |
| 2026-01-13 | Watson David O. | General Counsel | Sell | 6 k | 22,19 | 128 k USD |
| 2026-01-13 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 4 k | 22,19 | 86 k USD |
| 2026-01-13 | Nicholson Nur | Chief Technical Officer | Sell | 3 k | 22,19 | 58 k USD |
| 2026-01-13 | Francois Cedric | Chief Executive Officer | Sell | 10 k | 22,19 | 226 k USD |
| 2026-01-13 | Deschatelets Pascal | Chief Scientific Officer | Sell | 2 k | 22,19 | 51 k USD |
| 2026-01-13 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 2 k | 22,19 | 39 k USD |
| 2026-01-13 | Chopas James George | VP/Chief Accounting Officer | Sell | 873 | 22,19 | 19 k USD |
| 2026-01-13 | Chopas James George | VP/Chief Accounting Officer | Sell | 873 | 22,19 | 19 k USD |
| 2026-01-13 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 2 k | 22,19 | 39 k USD |
| 2026-01-13 | Deschatelets Pascal | Chief Scientific Officer | Sell | 2 k | 22,19 | 51 k USD |
| 2026-01-13 | Francois Cedric | Chief Executive Officer | Sell | 10 k | 22,19 | 226 k USD |
| 2026-01-13 | Nicholson Nur | Chief Technical Officer | Sell | 3 k | 22,19 | 58 k USD |
| 2026-01-13 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 4 k | 22,19 | 86 k USD |
| 2026-01-13 | Watson David O. | General Counsel | Sell | 6 k | 22,19 | 128 k USD |
| 2026-01-07 | Watson David O. | General Counsel | Buy | 888 | 14,95 | 13 k USD |
| 2026-01-07 | Watson David O. | General Counsel | Buy | 888 | 14,95 | 13 k USD |
| 2026-01-05 | Baumal Caroline | Chief Medical Officer | Sell | 3 k | 25,53 | 77 k USD |
| 2026-01-05 | Baumal Caroline | Chief Medical Officer | Sell | 3 k | 25,53 | 77 k USD |
| 2026-01-01 | WHEELER CRAIG A | Director | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-01 | Walbert Keli | Director | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-01 | FONTEYNE PAUL R. | Director | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-01 | O'Brien Stephanie Monaghan | Director | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-01 | Chan Gerald | Director | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-01 | Dunlop A. Sinclair | Director | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-01 | Machiels Alec | Director | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-01 | Chan Gerald | Director | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-01 | Dunlop A. Sinclair | Director | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-01 | FONTEYNE PAUL R. | Director | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-01 | Machiels Alec | Director | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-01 | O'Brien Stephanie Monaghan | Director | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-01 | WHEELER CRAIG A | Director | Buy | 8 k | 0,00 | 0 USD |
| 2026-01-01 | Walbert Keli | Director | Buy | 8 k | 0,00 | 0 USD |
| 2025-12-16 | Watson David O. | General Counsel | Sell | 5 k | 24,49 | 122 k USD |
| 2025-12-16 | Watson David O. | General Counsel | Sell | 5 k | 24,49 | 122 k USD |
| 2025-11-17 | Watson David O. | General Counsel | Sell | 5 k | 20,06 | 100 k USD |
| 2025-11-17 | Watson David O. | General Counsel | Sell | 5 k | 20,06 | 100 k USD |
| 2025-10-21 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 10 k | 10,03 | 100 k USD |
| 2025-10-21 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 10 k | 28,03 | 280 k USD |
| 2025-10-21 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 10 k | 10,03 | 100 k USD |
| 2025-10-21 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 10 k | 28,03 | 280 k USD |
| 2025-10-16 | Watson David O. | General Counsel | Sell | 5 k | 25,22 | 126 k USD |
| 2025-10-16 | Watson David O. | General Counsel | Sell | 5 k | 25,22 | 126 k USD |
| 2025-10-10 | Dunlop A. Sinclair | Director | Sell | 31 k | 23,72 | 738 k USD |
| 2025-10-10 | Dunlop A. Sinclair | Director | Sell | 4 k | 0,00 | 0 USD |
| 2025-10-10 | Dunlop A. Sinclair | Director | Sell | 31 k | 23,72 | 738 k USD |
| 2025-10-10 | Dunlop A. Sinclair | Director | Sell | 4 k | 0,00 | 0 USD |
| 2025-09-30 | Dunlop A. Sinclair | Director | Sell | 31 k | 22,58 | 702 k USD |
| 2025-09-30 | Dunlop A. Sinclair | Director | Sell | 4 k | 0,00 | 0 USD |
| 2025-09-30 | Dunlop A. Sinclair | Director | Sell | 31 k | 22,58 | 702 k USD |
| 2025-09-30 | Dunlop A. Sinclair | Director | Sell | 4 k | 0,00 | 0 USD |
| 2025-09-19 | Dunlop A. Sinclair | Director | Sell | 31 k | 22,95 | 714 k USD |
| 2025-09-19 | Dunlop A. Sinclair | Director | Sell | 4 k | 0,00 | 0 USD |
| 2025-09-19 | Dunlop A. Sinclair | Director | Sell | 31 k | 22,95 | 714 k USD |
| 2025-09-19 | Dunlop A. Sinclair | Director | Sell | 4 k | 0,00 | 0 USD |
| 2025-09-16 | Watson David O. | General Counsel | Sell | 5 k | 24,34 | 122 k USD |
| 2025-09-16 | Watson David O. | General Counsel | Sell | 5 k | 24,34 | 122 k USD |
| 2025-09-15 | Chopas James George | VP/Chief Accounting Officer | Sell | 189 | 24,19 | 5 k USD |
| 2025-09-15 | Chopas James George | VP/Chief Accounting Officer | Sell | 189 | 24,19 | 5 k USD |
| 2025-09-10 | Watson David O. | General Counsel | Sell | 20 k | 26,17 | 523 k USD |
| 2025-09-10 | Watson David O. | General Counsel | Sell | 20 k | 26,17 | 523 k USD |
| 2025-09-08 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 15 k | 10,03 | 150 k USD |
| 2025-09-08 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 33 k | 27,86 | 912 k USD |
| 2025-09-08 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 10 k | 27,83 | 278 k USD |
| 2025-09-08 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 15 k | 10,03 | 150 k USD |
| 2025-09-08 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 33 k | 27,86 | 912 k USD |
| 2025-09-08 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 10 k | 27,83 | 278 k USD |
| 2025-09-02 | Boucher Kelley | Chief People Officer | Buy | 30 k | 0,00 | 0 USD |
| 2025-09-02 | Chopas James George | VP/Chief Accounting Officer | Sell | 548 | 28,08 | 15 k USD |
| 2025-09-02 | Boucher Kelley | Chief People Officer | Buy | 30 k | 0,00 | 0 USD |
| 2025-09-02 | Chopas James George | VP/Chief Accounting Officer | Sell | 548 | 28,08 | 15 k USD |
| 2025-08-28 | Francois Cedric | Chief Executive Officer | Sell | 50 k | 28,39 | 1.4 mn USD |
| 2025-08-28 | Francois Cedric | Chief Executive Officer | Sell | 50 k | 28,39 | 1.4 mn USD |
| 2025-08-27 | Francois Cedric | Chief Executive Officer | Sell | 175 k | 28,19 | 4.9 mn USD |
| 2025-08-27 | Francois Cedric | Chief Executive Officer | Sell | 175 k | 28,19 | 4.9 mn USD |
| 2025-08-26 | MELTZER LESLIE | Chief Research and Development | Buy | 62 k | 0,00 | 0 USD |
| 2025-08-26 | MELTZER LESLIE | Chief Research and Development | Buy | 62 k | 0,00 | 0 USD |
| 2025-08-18 | Watson David O. | General Counsel | Sell | 5 k | 27,80 | 139 k USD |
| 2025-08-18 | Watson David O. | General Counsel | Sell | 5 k | 27,80 | 139 k USD |
| 2025-07-17 | Francois Cedric | Chief Executive Officer | Buy | 9 k | 4,31 | 39 k USD |
| 2025-07-17 | Francois Cedric | Chief Executive Officer | Sell | 20 k | 20,21 | 399 k USD |
| 2025-07-17 | Francois Cedric | Chief Executive Officer | Buy | 9 k | 4,31 | 39 k USD |
| 2025-07-17 | Francois Cedric | Chief Executive Officer | Sell | 20 k | 20,21 | 399 k USD |
| 2025-07-16 | Watson David O. | General Counsel | Sell | 5 k | 19,55 | 98 k USD |
| 2025-07-16 | Watson David O. | General Counsel | Sell | 5 k | 19,55 | 98 k USD |
| 2025-07-15 | Francois Cedric | Chief Executive Officer | Buy | 800 | 4,31 | 3 k USD |
| 2025-07-15 | Francois Cedric | Chief Executive Officer | Sell | 2 k | 20,09 | 38 k USD |
| 2025-07-15 | Francois Cedric | Chief Executive Officer | Buy | 800 | 4,31 | 3 k USD |
| 2025-07-15 | Francois Cedric | Chief Executive Officer | Sell | 2 k | 20,09 | 38 k USD |
| 2025-07-14 | Francois Cedric | Chief Executive Officer | Buy | 65 k | 4,31 | 281 k USD |
| 2025-07-14 | Francois Cedric | Chief Executive Officer | Sell | 137 k | 20,19 | 2.8 mn USD |
| 2025-07-14 | Francois Cedric | Chief Executive Officer | Buy | 65 k | 4,31 | 281 k USD |
| 2025-07-14 | Francois Cedric | Chief Executive Officer | Sell | 137 k | 20,19 | 2.8 mn USD |
| 2025-06-24 | Dunlop A. Sinclair | Director | Sell | 5 k | 0,00 | 0 USD |
| 2025-06-24 | Dunlop A. Sinclair | Director | Sell | 5 k | 0,00 | 0 USD |
| 2025-06-18 | Chopas James George | VP/Chief Accounting Officer | Buy | 6 k | 0,00 | 0 USD |
| 2025-06-18 | Chopas James George | VP/Chief Accounting Officer | Buy | 6 k | 0,00 | 0 USD |
| 2025-06-16 | Watson David O. | General Counsel | Sell | 5 k | 18,77 | 94 k USD |
| 2025-06-16 | Watson David O. | General Counsel | Sell | 5 k | 18,77 | 94 k USD |
| 2025-06-09 | Boucher Kelley | Chief People Officer | Buy | 45 k | 0,00 | 0 USD |
| 2025-06-09 | Boucher Kelley | Chief People Officer | Buy | 45 k | 0,00 | 0 USD |
| 2025-05-28 | Boucher Kelley | Chief People Officer | Buy | 22 k | 0,00 | 0 USD |
| 2025-05-28 | Boucher Kelley | Chief People Officer | Buy | 22 k | 0,00 | 0 USD |
| 2025-05-21 | Deschatelets Pascal | Chief Scientific Officer | Buy | 13 k | 3,76 | 48 k USD |
| 2025-05-21 | Deschatelets Pascal | Chief Scientific Officer | Buy | 13 k | 3,76 | 48 k USD |
| 2025-04-17 | WHEELER CRAIG A | Director | Buy | 16 k | 0,00 | 0 USD |
| 2025-04-17 | WHEELER CRAIG A | Director | Buy | 16 k | 0,00 | 0 USD |
| 2025-03-17 | Chopas James George | VP/Chief Accounting Officer | Sell | 183 | 24,82 | 5 k USD |
| 2025-03-17 | Chopas James George | VP/Chief Accounting Officer | Sell | 183 | 24,82 | 5 k USD |
| 2025-03-05 | Watson David O. | General Counsel | Sell | 6 k | 25,10 | 140 k USD |
| 2025-03-05 | Watson David O. | General Counsel | Sell | 6 k | 25,10 | 140 k USD |
| 2025-03-04 | Watson David O. | General Counsel | Sell | 7 k | 0,00 | 0 USD |
| 2025-03-04 | Watson David O. | General Counsel | Buy | 7 k | 0,00 | 0 USD |
| 2025-03-04 | Watson David O. | General Counsel | Sell | 7 k | 0,00 | 0 USD |
| 2025-03-04 | Watson David O. | General Counsel | Buy | 7 k | 0,00 | 0 USD |
| 2025-02-11 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 363 | 28,54 | 10 k USD |
| 2025-02-11 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 363 | 28,54 | 10 k USD |
| 2025-01-29 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 365 | 29,52 | 11 k USD |
| 2025-01-29 | Francois Cedric | Chief Executive Officer | Sell | 3 k | 29,52 | 83 k USD |
| 2025-01-29 | Deschatelets Pascal | Chief Scientific Officer | Sell | 826 | 29,52 | 24 k USD |
| 2025-01-29 | Eisele Jeffrey | Chief Development Officer | Sell | 278 | 29,52 | 8 k USD |
| 2025-01-29 | Lewis Karen | Chief People Officer | Sell | 364 | 29,52 | 11 k USD |
| 2025-01-29 | Nicholson Nur | Chief Technical Officer | Sell | 825 | 29,52 | 24 k USD |
| 2025-01-29 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 546 | 29,52 | 16 k USD |
| 2025-01-29 | Townsend Adam J. | Chief Commercial Officer | Sell | 695 | 29,52 | 21 k USD |
| 2025-01-29 | Watson David O. | General Counsel | Sell | 695 | 29,52 | 21 k USD |
| 2025-01-29 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 365 | 29,52 | 11 k USD |
| 2025-01-29 | Deschatelets Pascal | Chief Scientific Officer | Sell | 826 | 29,52 | 24 k USD |
| 2025-01-29 | Eisele Jeffrey | Chief Development Officer | Sell | 278 | 29,52 | 8 k USD |
| 2025-01-29 | Francois Cedric | Chief Executive Officer | Sell | 3 k | 29,52 | 83 k USD |
| 2025-01-29 | Lewis Karen | Chief People Officer | Sell | 364 | 29,52 | 11 k USD |
| 2025-01-29 | Nicholson Nur | Chief Technical Officer | Sell | 825 | 29,52 | 24 k USD |
| 2025-01-29 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 546 | 29,52 | 16 k USD |
| 2025-01-29 | Townsend Adam J. | Chief Commercial Officer | Sell | 695 | 29,52 | 21 k USD |
| 2025-01-29 | Watson David O. | General Counsel | Sell | 695 | 29,52 | 21 k USD |
| 2025-01-22 | Chopas James George | VP/Chief Accounting Officer | Sell | 1 k | 30,43 | 33 k USD |
| 2025-01-22 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 1 k | 30,43 | 42 k USD |
| 2025-01-22 | Deschatelets Pascal | Chief Scientific Officer | Sell | 4 k | 30,43 | 120 k USD |
| 2025-01-22 | Eisele Jeffrey | Chief Development Officer | Sell | 1 k | 30,43 | 39 k USD |
| 2025-01-22 | Francois Cedric | Chief Executive Officer | Sell | 14 k | 30,43 | 412 k USD |
| 2025-01-22 | Lewis Karen | Chief People Officer | Sell | 2 k | 30,43 | 53 k USD |
| 2025-01-22 | Nicholson Nur | Chief Technical Officer | Sell | 4 k | 30,43 | 120 k USD |
| 2025-01-22 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 3 k | 30,43 | 94 k USD |
| 2025-01-22 | Townsend Adam J. | Chief Commercial Officer | Sell | 3 k | 30,43 | 101 k USD |
| 2025-01-22 | Watson David O. | General Counsel | Sell | 3 k | 30,43 | 101 k USD |
| 2025-01-22 | Chopas James George | VP/Chief Accounting Officer | Sell | 1 k | 30,43 | 33 k USD |
| 2025-01-22 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 1 k | 30,43 | 42 k USD |
| 2025-01-22 | Deschatelets Pascal | Chief Scientific Officer | Sell | 4 k | 30,43 | 120 k USD |
| 2025-01-22 | Eisele Jeffrey | Chief Development Officer | Sell | 1 k | 30,43 | 39 k USD |
| 2025-01-22 | Francois Cedric | Chief Executive Officer | Sell | 14 k | 30,43 | 412 k USD |
| 2025-01-22 | Lewis Karen | Chief People Officer | Sell | 2 k | 30,43 | 53 k USD |
| 2025-01-22 | Nicholson Nur | Chief Technical Officer | Sell | 4 k | 30,43 | 120 k USD |
| 2025-01-22 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 3 k | 30,43 | 94 k USD |
| 2025-01-22 | Townsend Adam J. | Chief Commercial Officer | Sell | 3 k | 30,43 | 101 k USD |
| 2025-01-22 | Watson David O. | General Counsel | Sell | 3 k | 30,43 | 101 k USD |
| 2025-01-21 | Baumal Caroline | Chief Medical Officer | Buy | 40 k | 0,00 | 0 USD |
| 2025-01-21 | Chopas James George | VP/Chief Accounting Officer | Buy | 13 k | 0,00 | 0 USD |
| 2025-01-21 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Buy | 29 k | 0,00 | 0 USD |
| 2025-01-21 | Deschatelets Pascal | Chief Scientific Officer | Buy | 15 k | 0,00 | 0 USD |
| 2025-01-21 | Francois Cedric | Chief Executive Officer | Buy | 131 k | 0,00 | 0 USD |
| 2025-01-21 | Lewis Karen | Chief People Officer | Buy | 29 k | 0,00 | 0 USD |
| 2025-01-21 | Nicholson Nur | Chief Technical Officer | Buy | 36 k | 0,00 | 0 USD |
| 2025-01-21 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 46 k | 0,00 | 0 USD |
| 2025-01-21 | Watson David O. | General Counsel | Buy | 43 k | 0,00 | 0 USD |
| 2025-01-21 | Baumal Caroline | Chief Medical Officer | Buy | 40 k | 0,00 | 0 USD |
| 2025-01-21 | Chopas James George | VP/Chief Accounting Officer | Buy | 13 k | 0,00 | 0 USD |
| 2025-01-21 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Buy | 29 k | 0,00 | 0 USD |
| 2025-01-21 | Deschatelets Pascal | Chief Scientific Officer | Buy | 15 k | 0,00 | 0 USD |
| 2025-01-21 | Francois Cedric | Chief Executive Officer | Buy | 131 k | 0,00 | 0 USD |
| 2025-01-21 | Lewis Karen | Chief People Officer | Buy | 29 k | 0,00 | 0 USD |
| 2025-01-21 | Nicholson Nur | Chief Technical Officer | Buy | 36 k | 0,00 | 0 USD |
| 2025-01-21 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 46 k | 0,00 | 0 USD |
| 2025-01-21 | Watson David O. | General Counsel | Buy | 43 k | 0,00 | 0 USD |
| 2025-01-17 | Baumal Caroline | Chief Medical Officer | Sell | 2 k | 29,96 | 56 k USD |
| 2025-01-17 | Chopas James George | VP/Chief Accounting Officer | Sell | 715 | 29,96 | 21 k USD |
| 2025-01-17 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 1 k | 29,96 | 37 k USD |
| 2025-01-17 | Deschatelets Pascal | Chief Scientific Officer | Sell | 750 | 29,96 | 22 k USD |
| 2025-01-17 | Francois Cedric | Chief Executive Officer | Sell | 6 k | 29,96 | 180 k USD |
| 2025-01-17 | Lewis Karen | Chief People Officer | Sell | 1 k | 29,96 | 37 k USD |
| 2025-01-17 | Nicholson Nur | Chief Technical Officer | Sell | 2 k | 29,96 | 64 k USD |
| 2025-01-17 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 2 k | 29,96 | 52 k USD |
| 2025-01-17 | Townsend Adam J. | Chief Commercial Officer | Sell | 2 k | 29,96 | 66 k USD |
| 2025-01-17 | Watson David O. | General Counsel | Sell | 2 k | 29,96 | 66 k USD |
| 2025-01-17 | Baumal Caroline | Chief Medical Officer | Sell | 2 k | 29,96 | 56 k USD |
| 2025-01-17 | Chopas James George | VP/Chief Accounting Officer | Sell | 715 | 29,96 | 21 k USD |
| 2025-01-17 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 1 k | 29,96 | 37 k USD |
| 2025-01-17 | Deschatelets Pascal | Chief Scientific Officer | Sell | 750 | 29,96 | 22 k USD |
| 2025-01-17 | Francois Cedric | Chief Executive Officer | Sell | 6 k | 29,96 | 180 k USD |
| 2025-01-17 | Lewis Karen | Chief People Officer | Sell | 1 k | 29,96 | 37 k USD |
| 2025-01-17 | Nicholson Nur | Chief Technical Officer | Sell | 2 k | 29,96 | 64 k USD |
| 2025-01-17 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 2 k | 29,96 | 52 k USD |
| 2025-01-17 | Townsend Adam J. | Chief Commercial Officer | Sell | 2 k | 29,96 | 66 k USD |
| 2025-01-17 | Watson David O. | General Counsel | Sell | 2 k | 29,96 | 66 k USD |
| 2025-01-13 | Chopas James George | VP/Chief Accounting Officer | Sell | 783 | 28,70 | 22 k USD |
| 2025-01-13 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 2 k | 28,70 | 46 k USD |
| 2025-01-13 | Deschatelets Pascal | Chief Scientific Officer | Sell | 2 k | 28,70 | 66 k USD |
| 2025-01-13 | Eisele Jeffrey | Chief Development Officer | Sell | 264 | 28,70 | 8 k USD |
| 2025-01-13 | Francois Cedric | Chief Executive Officer | Sell | 6 k | 28,70 | 179 k USD |
| 2025-01-13 | Lewis Karen | Chief People Officer | Sell | 2 k | 28,70 | 46 k USD |
| 2025-01-13 | Nicholson Nur | Chief Technical Officer | Sell | 3 k | 28,70 | 76 k USD |
| 2025-01-13 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 2 k | 28,70 | 62 k USD |
| 2025-01-13 | Townsend Adam J. | Chief Commercial Officer | Sell | 3 k | 28,70 | 77 k USD |
| 2025-01-13 | Watson David O. | General Counsel | Sell | 5 k | 28,70 | 143 k USD |
| 2025-01-13 | Chopas James George | VP/Chief Accounting Officer | Sell | 783 | 28,70 | 22 k USD |
| 2025-01-13 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 2 k | 28,70 | 46 k USD |
| 2025-01-13 | Deschatelets Pascal | Chief Scientific Officer | Sell | 2 k | 28,70 | 66 k USD |
| 2025-01-13 | Eisele Jeffrey | Chief Development Officer | Sell | 264 | 28,70 | 8 k USD |
| 2025-01-13 | Francois Cedric | Chief Executive Officer | Sell | 6 k | 28,70 | 179 k USD |
| 2025-01-13 | Lewis Karen | Chief People Officer | Sell | 2 k | 28,70 | 46 k USD |
| 2025-01-13 | Nicholson Nur | Chief Technical Officer | Sell | 3 k | 28,70 | 76 k USD |
| 2025-01-13 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 2 k | 28,70 | 62 k USD |
| 2025-01-13 | Townsend Adam J. | Chief Commercial Officer | Sell | 3 k | 28,70 | 77 k USD |
| 2025-01-13 | Watson David O. | General Counsel | Sell | 5 k | 28,70 | 143 k USD |
| 2025-01-08 | Walbert Keli | Director | Buy | 9 k | 0,00 | 0 USD |
| 2025-01-08 | Walbert Keli | Director | Buy | 9 k | 0,00 | 0 USD |
| 2025-01-06 | Baumal Caroline | Chief Medical Officer | Sell | 3 k | 33,81 | 95 k USD |
| 2025-01-06 | Baumal Caroline | Chief Medical Officer | Sell | 3 k | 33,81 | 95 k USD |
| 2025-01-01 | Chan Gerald | Director | Buy | 6 k | 0,00 | 0 USD |
| 2025-01-01 | Dunlop A. Sinclair | Director | Buy | 6 k | 0,00 | 0 USD |
| 2025-01-01 | FONTEYNE PAUL R. | Director | Buy | 6 k | 0,00 | 0 USD |
| 2025-01-01 | Machiels Alec | Director | Buy | 6 k | 0,00 | 0 USD |
| 2025-01-01 | O'Brien Stephanie Monaghan | Director | Buy | 6 k | 0,00 | 0 USD |
| 2025-01-01 | Chan Gerald | Director | Buy | 6 k | 0,00 | 0 USD |
| 2025-01-01 | Dunlop A. Sinclair | Director | Buy | 6 k | 0,00 | 0 USD |
| 2025-01-01 | FONTEYNE PAUL R. | Director | Buy | 6 k | 0,00 | 0 USD |
| 2025-01-01 | Machiels Alec | Director | Buy | 6 k | 0,00 | 0 USD |
| 2025-01-01 | O'Brien Stephanie Monaghan | Director | Buy | 6 k | 0,00 | 0 USD |
| 2024-12-31 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 1 k | 14,95 | 16 k USD |
| 2024-12-31 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 10 k | 13,85 | 139 k USD |
| 2024-12-31 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 1 k | 14,95 | 16 k USD |
| 2024-12-31 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 10 k | 13,85 | 139 k USD |
| 2024-12-23 | Eisele Jeffrey | Chief Development Officer | Sell | 63 | 33,09 | 2 k USD |
| 2024-12-23 | Eisele Jeffrey | Chief Development Officer | Sell | 63 | 33,09 | 2 k USD |
| 2024-12-11 | Watson David O. | General Counsel | Sell | 5 k | 34,24 | 171 k USD |
| 2024-12-11 | Watson David O. | General Counsel | Sell | 5 k | 34,24 | 171 k USD |
| 2024-11-01 | Francois Cedric | Chief Executive Officer | Sell | 182 k | 0,00 | 0 USD |
| 2024-11-01 | Francois Cedric | Chief Executive Officer | Sell | 182 k | 0,00 | 0 USD |
| 2024-09-27 | Watson David O. | General Counsel | Sell | 11 k | 0,00 | 0 USD |
| 2024-09-27 | Watson David O. | General Counsel | Buy | 11 k | 0,00 | 0 USD |
| 2024-09-27 | Watson David O. | General Counsel | Sell | 11 k | 0,00 | 0 USD |
| 2024-09-27 | Watson David O. | General Counsel | Buy | 11 k | 0,00 | 0 USD |
| 2024-09-23 | Dunlop A. Sinclair | Director | Buy | 5 k | 13,19 | 61 k USD |
| 2024-09-23 | Dunlop A. Sinclair | Director | Buy | 5 k | 13,19 | 61 k USD |
| 2024-09-16 | Dunlop A. Sinclair | Director | Sell | 29 k | 36,09 | 1.1 mn USD |
| 2024-09-16 | Dunlop A. Sinclair | Director | Sell | 8 k | 36,79 | 277 k USD |
| 2024-09-16 | Chopas James George | VP/Chief Accounting Officer | Sell | 192 | 36,21 | 7 k USD |
| 2024-09-16 | Chopas James George | VP/Chief Accounting Officer | Sell | 192 | 36,21 | 7 k USD |
| 2024-09-16 | Dunlop A. Sinclair | Director | Sell | 29 k | 36,09 | 1.1 mn USD |
| 2024-09-16 | Dunlop A. Sinclair | Director | Sell | 8 k | 36,79 | 277 k USD |
| 2024-09-03 | Chopas James George | VP/Chief Accounting Officer | Sell | 550 | 39,49 | 22 k USD |
| 2024-09-03 | Chopas James George | VP/Chief Accounting Officer | Sell | 550 | 39,49 | 22 k USD |
| 2024-08-12 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Buy | 5 k | 13,85 | 72 k USD |
| 2024-08-12 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Buy | 5 k | 13,85 | 72 k USD |
| 2024-06-28 | Dunlop A. Sinclair | Director | Buy | 900 | 13,19 | 12 k USD |
| 2024-06-28 | Dunlop A. Sinclair | Director | Buy | 900 | 13,19 | 12 k USD |
| 2024-06-21 | Dunlop A. Sinclair | Director | Sell | 35 k | 39,22 | 1.4 mn USD |
| 2024-06-21 | Dunlop A. Sinclair | Director | Sell | 2 k | 39,63 | 67 k USD |
| 2024-06-21 | Dunlop A. Sinclair | Director | Sell | 35 k | 39,22 | 1.4 mn USD |
| 2024-06-21 | Dunlop A. Sinclair | Director | Sell | 2 k | 39,63 | 67 k USD |
| 2024-05-20 | Deschatelets Pascal | Chief Scientific Officer | Buy | 25 k | 3,76 | 92 k USD |
| 2024-05-20 | Deschatelets Pascal | Chief Scientific Officer | Buy | 25 k | 3,76 | 92 k USD |
| 2024-05-08 | Deschatelets Pascal | Chief Scientific Officer | Buy | 79 k | 4,31 | 340 k USD |
| 2024-05-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 56 k | 42,15 | 2.4 mn USD |
| 2024-05-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 22 k | 42,85 | 963 k USD |
| 2024-05-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 100 | 44,03 | 4 k USD |
| 2024-05-08 | Deschatelets Pascal | Chief Scientific Officer | Buy | 79 k | 4,31 | 340 k USD |
| 2024-05-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 56 k | 42,15 | 2.4 mn USD |
| 2024-05-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 22 k | 42,85 | 963 k USD |
| 2024-05-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 100 | 44,03 | 4 k USD |
| 2024-04-18 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 14 k | 0,00 | 0 USD |
| 2024-04-18 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 14 k | 0,00 | 0 USD |
| 2024-04-18 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 14 k | 0,00 | 0 USD |
| 2024-04-18 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 14 k | 0,00 | 0 USD |
| 2024-04-12 | Dunlop A. Sinclair | Director | Buy | 2 k | 13,19 | 20 k USD |
| 2024-04-12 | Dunlop A. Sinclair | Director | Buy | 2 k | 13,19 | 20 k USD |
| 2024-04-08 | Deschatelets Pascal | Chief Scientific Officer | Buy | 69 k | 3,76 | 260 k USD |
| 2024-04-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 64 k | 54,12 | 3.5 mn USD |
| 2024-04-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 5 k | 54,92 | 260 k USD |
| 2024-04-08 | Deschatelets Pascal | Chief Scientific Officer | Buy | 69 k | 3,76 | 260 k USD |
| 2024-04-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 64 k | 54,12 | 3.5 mn USD |
| 2024-04-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 5 k | 54,92 | 260 k USD |
| 2024-04-01 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 4 k | 10,03 | 40 k USD |
| 2024-04-01 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 4 k | 58,66 | 235 k USD |
| 2024-04-01 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 4 k | 10,03 | 40 k USD |
| 2024-04-01 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 4 k | 58,66 | 235 k USD |
| 2024-03-19 | Dunlop A. Sinclair | Director | Sell | 19 k | 57,18 | 1.1 mn USD |
| 2024-03-19 | Dunlop A. Sinclair | Director | Sell | 19 k | 57,18 | 1.1 mn USD |
| 2024-03-18 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 10 k | 56,90 | 564 k USD |
| 2024-03-18 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 10 k | 56,90 | 564 k USD |
| 2024-03-15 | Chopas James George | VP/Chief Accounting Officer | Sell | 184 | 56,46 | 10 k USD |
| 2024-03-15 | Chopas James George | VP/Chief Accounting Officer | Sell | 184 | 56,46 | 10 k USD |
| 2024-03-13 | Nicholson Nur | Chief Technical Officer | Sell | 8 k | 57,31 | 445 k USD |
| 2024-03-13 | Nicholson Nur | Chief Technical Officer | Sell | 3 k | 58,13 | 201 k USD |
| 2024-03-13 | Nicholson Nur | Chief Technical Officer | Sell | 8 k | 57,31 | 445 k USD |
| 2024-03-13 | Nicholson Nur | Chief Technical Officer | Sell | 3 k | 58,13 | 201 k USD |
| 2024-03-08 | Deschatelets Pascal | Chief Scientific Officer | Buy | 69 k | 3,67 | 254 k USD |
| 2024-03-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 43 k | 61,88 | 2.6 mn USD |
| 2024-03-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 26 k | 62,69 | 1.6 mn USD |
| 2024-03-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 100 | 63,35 | 6 k USD |
| 2024-03-08 | Deschatelets Pascal | Chief Scientific Officer | Buy | 69 k | 3,67 | 254 k USD |
| 2024-03-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 43 k | 61,88 | 2.6 mn USD |
| 2024-03-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 26 k | 62,69 | 1.6 mn USD |
| 2024-03-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 100 | 63,35 | 6 k USD |
| 2024-03-06 | Watson David O. | General Counsel | Buy | 4 k | 13,85 | 52 k USD |
| 2024-03-06 | Watson David O. | General Counsel | Buy | 4 k | 13,85 | 52 k USD |
| 2024-03-01 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 6 k | 10,03 | 60 k USD |
| 2024-03-01 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 4 k | 62,86 | 251 k USD |
| 2024-03-01 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 2 k | 63,95 | 128 k USD |
| 2024-03-01 | Francois Cedric | Chief Executive Officer | Buy | 50 k | 3,76 | 188 k USD |
| 2024-03-01 | Francois Cedric | Chief Executive Officer | Buy | 200 k | 4,31 | 862 k USD |
| 2024-03-01 | Francois Cedric | Chief Executive Officer | Sell | 29 k | 62,21 | 1.8 mn USD |
| 2024-03-01 | Francois Cedric | Chief Executive Officer | Sell | 42 k | 62,96 | 2.6 mn USD |
| 2024-03-01 | Francois Cedric | Chief Executive Officer | Sell | 63 k | 64,26 | 4.0 mn USD |
| 2024-03-01 | Francois Cedric | Chief Executive Officer | Sell | 117 k | 64,92 | 7.6 mn USD |
| 2024-03-01 | Francois Cedric | Chief Executive Officer | Sell | 413 | 65,68 | 27 k USD |
| 2024-03-01 | Francois Cedric | Chief Executive Officer | Buy | 50 k | 3,76 | 188 k USD |
| 2024-03-01 | Francois Cedric | Chief Executive Officer | Buy | 200 k | 4,31 | 862 k USD |
| 2024-03-01 | Francois Cedric | Chief Executive Officer | Sell | 29 k | 62,21 | 1.8 mn USD |
| 2024-03-01 | Francois Cedric | Chief Executive Officer | Sell | 42 k | 62,96 | 2.6 mn USD |
| 2024-03-01 | Francois Cedric | Chief Executive Officer | Sell | 63 k | 64,26 | 4.0 mn USD |
| 2024-03-01 | Francois Cedric | Chief Executive Officer | Sell | 117 k | 64,92 | 7.6 mn USD |
| 2024-03-01 | Francois Cedric | Chief Executive Officer | Sell | 413 | 65,68 | 27 k USD |
| 2024-03-01 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 6 k | 10,03 | 60 k USD |
| 2024-03-01 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 4 k | 62,86 | 251 k USD |
| 2024-03-01 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 2 k | 63,95 | 128 k USD |
| 2024-02-12 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 597 | 67,77 | 40 k USD |
| 2024-02-12 | Deschatelets Pascal | Chief Scientific Officer | Sell | 1 k | 67,77 | 78 k USD |
| 2024-02-12 | Francois Cedric | Chief Executive Officer | Sell | 4 k | 67,77 | 268 k USD |
| 2024-02-12 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 1 k | 67,77 | 97 k USD |
| 2024-02-12 | Townsend Adam J. | Chief Commercial Officer | Sell | 1 k | 67,77 | 78 k USD |
| 2024-02-12 | Watson David O. | General Counsel | Sell | 781 | 67,77 | 53 k USD |
| 2024-02-12 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 597 | 67,77 | 40 k USD |
| 2024-02-12 | Deschatelets Pascal | Chief Scientific Officer | Sell | 1 k | 67,77 | 78 k USD |
| 2024-02-12 | Francois Cedric | Chief Executive Officer | Sell | 4 k | 67,77 | 268 k USD |
| 2024-02-12 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 1 k | 67,77 | 97 k USD |
| 2024-02-12 | Townsend Adam J. | Chief Commercial Officer | Sell | 1 k | 67,77 | 78 k USD |
| 2024-02-12 | Watson David O. | General Counsel | Sell | 781 | 67,77 | 53 k USD |
| 2024-01-30 | Eisele Jeffrey | Chief Development Officer | Sell | 971 | 65,53 | 64 k USD |
| 2024-01-30 | Lewis Karen | Chief People Officer | Sell | 883 | 65,53 | 58 k USD |
| 2024-01-30 | Eisele Jeffrey | Chief Development Officer | Sell | 971 | 65,53 | 64 k USD |
| 2024-01-30 | Lewis Karen | Chief People Officer | Sell | 883 | 65,53 | 58 k USD |
| 2024-01-29 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 367 | 64,14 | 24 k USD |
| 2024-01-29 | Deschatelets Pascal | Chief Scientific Officer | Sell | 874 | 64,14 | 56 k USD |
| 2024-01-29 | Eisele Jeffrey | Chief Development Officer | Sell | 279 | 64,14 | 18 k USD |
| 2024-01-29 | Francois Cedric | Chief Executive Officer | Sell | 3 k | 64,14 | 182 k USD |
| 2024-01-29 | Lewis Karen | Chief People Officer | Sell | 367 | 64,14 | 24 k USD |
| 2024-01-29 | Nicholson Nur | Chief Technical Officer | Sell | 835 | 64,14 | 54 k USD |
| 2024-01-29 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 906 | 64,14 | 58 k USD |
| 2024-01-29 | Townsend Adam J. | Chief Commercial Officer | Sell | 906 | 64,14 | 58 k USD |
| 2024-01-29 | Watson David O. | General Counsel | Sell | 906 | 64,14 | 58 k USD |
| 2024-01-29 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 367 | 64,14 | 24 k USD |
| 2024-01-29 | Deschatelets Pascal | Chief Scientific Officer | Sell | 874 | 64,14 | 56 k USD |
| 2024-01-29 | Eisele Jeffrey | Chief Development Officer | Sell | 279 | 64,14 | 18 k USD |
| 2024-01-29 | Francois Cedric | Chief Executive Officer | Sell | 3 k | 64,14 | 182 k USD |
| 2024-01-29 | Lewis Karen | Chief People Officer | Sell | 367 | 64,14 | 24 k USD |
| 2024-01-29 | Nicholson Nur | Chief Technical Officer | Sell | 835 | 64,14 | 54 k USD |
| 2024-01-29 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 906 | 64,14 | 58 k USD |
| 2024-01-29 | Townsend Adam J. | Chief Commercial Officer | Sell | 906 | 64,14 | 58 k USD |
| 2024-01-29 | Watson David O. | General Counsel | Sell | 906 | 64,14 | 58 k USD |
| 2024-01-23 | Eisele Jeffrey | Chief Development Officer | Sell | 7 k | 63,69 | 470 k USD |
| 2024-01-23 | Lewis Karen | Chief People Officer | Sell | 4 k | 63,69 | 273 k USD |
| 2024-01-23 | Eisele Jeffrey | Chief Development Officer | Sell | 7 k | 63,69 | 470 k USD |
| 2024-01-23 | Lewis Karen | Chief People Officer | Sell | 4 k | 63,69 | 273 k USD |
| 2024-01-22 | Chopas James George | VP/Chief Accounting Officer | Sell | 1 k | 65,00 | 69 k USD |
| 2024-01-22 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 1 k | 65,00 | 90 k USD |
| 2024-01-22 | Deschatelets Pascal | Chief Scientific Officer | Sell | 4 k | 65,00 | 254 k USD |
| 2024-01-22 | Eisele Jeffrey | Chief Development Officer | Sell | 2 k | 65,00 | 104 k USD |
| 2024-01-22 | Lewis Karen | Chief People Officer | Sell | 2 k | 65,00 | 113 k USD |
| 2024-01-22 | Nicholson Nur | Chief Technical Officer | Sell | 3 k | 65,00 | 169 k USD |
| 2024-01-22 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 4 k | 65,00 | 231 k USD |
| 2024-01-22 | Townsend Adam J. | Chief Commercial Officer | Sell | 3 k | 65,00 | 222 k USD |
| 2024-01-22 | Watson David O. | General Counsel | Sell | 4 k | 65,00 | 272 k USD |
| 2024-01-22 | Francois Cedric | Chief Executive Officer | Sell | 13 k | 65,00 | 873 k USD |
| 2024-01-22 | Chopas James George | VP/Chief Accounting Officer | Sell | 1 k | 65,00 | 69 k USD |
| 2024-01-22 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 1 k | 65,00 | 90 k USD |
| 2024-01-22 | Deschatelets Pascal | Chief Scientific Officer | Sell | 4 k | 65,00 | 254 k USD |
| 2024-01-22 | Eisele Jeffrey | Chief Development Officer | Sell | 2 k | 65,00 | 104 k USD |
| 2024-01-22 | Francois Cedric | Chief Executive Officer | Sell | 13 k | 65,00 | 873 k USD |
| 2024-01-22 | Lewis Karen | Chief People Officer | Sell | 2 k | 65,00 | 113 k USD |
| 2024-01-22 | Nicholson Nur | Chief Technical Officer | Sell | 3 k | 65,00 | 169 k USD |
| 2024-01-22 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 4 k | 65,00 | 231 k USD |
| 2024-01-22 | Townsend Adam J. | Chief Commercial Officer | Sell | 3 k | 65,00 | 222 k USD |
| 2024-01-22 | Watson David O. | General Counsel | Sell | 4 k | 65,00 | 272 k USD |
| 2024-01-17 | Lewis Karen | Chief People Officer | Sell | 3 k | 65,58 | 215 k USD |
| 2024-01-17 | Eisele Jeffrey | Chief Development Officer | Sell | 5 k | 65,58 | 341 k USD |
| 2024-01-17 | Eisele Jeffrey | Chief Development Officer | Sell | 5 k | 65,58 | 341 k USD |
| 2024-01-17 | Lewis Karen | Chief People Officer | Sell | 3 k | 65,58 | 215 k USD |
| 2024-01-16 | Eisele Jeffrey | Chief Development Officer | Buy | 20 k | 0,00 | 0 USD |
| 2024-01-16 | Eisele Jeffrey | Chief Development Officer | Sell | 438 | 66,81 | 29 k USD |
| 2024-01-16 | Francois Cedric | Chief Executive Officer | Buy | 72 k | 0,00 | 0 USD |
| 2024-01-16 | Francois Cedric | Chief Executive Officer | Sell | 8 k | 66,81 | 525 k USD |
| 2024-01-16 | Baumal Caroline | Chief Medical Officer | Buy | 25 k | 0,00 | 0 USD |
| 2024-01-16 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 24 k | 0,00 | 0 USD |
| 2024-01-16 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 2 k | 66,81 | 149 k USD |
| 2024-01-16 | Townsend Adam J. | Chief Commercial Officer | Buy | 24 k | 0,00 | 0 USD |
| 2024-01-16 | Townsend Adam J. | Chief Commercial Officer | Sell | 2 k | 66,81 | 149 k USD |
| 2024-01-16 | Watson David O. | General Counsel | Buy | 24 k | 0,00 | 0 USD |
| 2024-01-16 | Watson David O. | General Counsel | Sell | 4 k | 66,81 | 283 k USD |
| 2024-01-16 | Nicholson Nur | Chief Technical Officer | Buy | 20 k | 0,00 | 0 USD |
| 2024-01-16 | Nicholson Nur | Chief Technical Officer | Sell | 2 k | 66,81 | 124 k USD |
| 2024-01-16 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Buy | 17 k | 0,00 | 0 USD |
| 2024-01-16 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 2 k | 66,81 | 109 k USD |
| 2024-01-16 | Lewis Karen | Chief People Officer | Buy | 17 k | 0,00 | 0 USD |
| 2024-01-16 | Lewis Karen | Chief People Officer | Sell | 2 k | 66,81 | 109 k USD |
| 2024-01-16 | Chopas James George | VP/Chief Accounting Officer | Buy | 8 k | 0,00 | 0 USD |
| 2024-01-16 | Chopas James George | VP/Chief Accounting Officer | Sell | 864 | 66,81 | 58 k USD |
| 2024-01-16 | Deschatelets Pascal | Chief Scientific Officer | Buy | 7 k | 0,00 | 0 USD |
| 2024-01-16 | Deschatelets Pascal | Chief Scientific Officer | Sell | 2 k | 66,81 | 109 k USD |
| 2024-01-16 | Baumal Caroline | Chief Medical Officer | Buy | 25 k | 0,00 | 0 USD |
| 2024-01-16 | Chopas James George | VP/Chief Accounting Officer | Buy | 8 k | 0,00 | 0 USD |
| 2024-01-16 | Chopas James George | VP/Chief Accounting Officer | Sell | 864 | 66,81 | 58 k USD |
| 2024-01-16 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Buy | 17 k | 0,00 | 0 USD |
| 2024-01-16 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 2 k | 66,81 | 109 k USD |
| 2024-01-16 | Deschatelets Pascal | Chief Scientific Officer | Buy | 7 k | 0,00 | 0 USD |
| 2024-01-16 | Deschatelets Pascal | Chief Scientific Officer | Sell | 2 k | 66,81 | 109 k USD |
| 2024-01-16 | Eisele Jeffrey | Chief Development Officer | Buy | 20 k | 0,00 | 0 USD |
| 2024-01-16 | Eisele Jeffrey | Chief Development Officer | Sell | 438 | 66,81 | 29 k USD |
| 2024-01-16 | Francois Cedric | Chief Executive Officer | Buy | 72 k | 0,00 | 0 USD |
| 2024-01-16 | Francois Cedric | Chief Executive Officer | Sell | 8 k | 66,81 | 525 k USD |
| 2024-01-16 | Lewis Karen | Chief People Officer | Buy | 17 k | 0,00 | 0 USD |
| 2024-01-16 | Lewis Karen | Chief People Officer | Sell | 2 k | 66,81 | 109 k USD |
| 2024-01-16 | Nicholson Nur | Chief Technical Officer | Buy | 20 k | 0,00 | 0 USD |
| 2024-01-16 | Nicholson Nur | Chief Technical Officer | Sell | 2 k | 66,81 | 124 k USD |
| 2024-01-16 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 24 k | 0,00 | 0 USD |
| 2024-01-16 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 2 k | 66,81 | 149 k USD |
| 2024-01-16 | Townsend Adam J. | Chief Commercial Officer | Buy | 24 k | 0,00 | 0 USD |
| 2024-01-16 | Townsend Adam J. | Chief Commercial Officer | Sell | 2 k | 66,81 | 149 k USD |
| 2024-01-16 | Watson David O. | General Counsel | Buy | 24 k | 0,00 | 0 USD |
| 2024-01-16 | Watson David O. | General Counsel | Sell | 4 k | 66,81 | 283 k USD |
| 2024-01-04 | Baumal Caroline | Chief Medical Officer | Sell | 3 k | 60,05 | 165 k USD |
| 2024-01-04 | Baumal Caroline | Chief Medical Officer | Sell | 3 k | 60,05 | 165 k USD |
| 2024-01-01 | Machiels Alec | Director | Buy | 3 k | 0,00 | 0 USD |
| 2024-01-01 | Dunlop A. Sinclair | Director | Buy | 3 k | 0,00 | 0 USD |
| 2024-01-01 | Chan Gerald | Director | Buy | 3 k | 0,00 | 0 USD |
| 2024-01-01 | O'Brien Stephanie Monaghan | Director | Buy | 3 k | 0,00 | 0 USD |
| 2024-01-01 | FONTEYNE PAUL R. | Director | Buy | 3 k | 0,00 | 0 USD |
| 2024-01-01 | Chan Gerald | Director | Buy | 3 k | 0,00 | 0 USD |
| 2024-01-01 | Dunlop A. Sinclair | Director | Buy | 3 k | 0,00 | 0 USD |
| 2024-01-01 | FONTEYNE PAUL R. | Director | Buy | 3 k | 0,00 | 0 USD |
| 2024-01-01 | Machiels Alec | Director | Buy | 3 k | 0,00 | 0 USD |
| 2024-01-01 | O'Brien Stephanie Monaghan | Director | Buy | 3 k | 0,00 | 0 USD |
| 2023-12-27 | Eisele Jeffrey | Chief Development Officer | Sell | 235 | 60,23 | 14 k USD |
| 2023-12-27 | Eisele Jeffrey | Chief Development Officer | Sell | 235 | 60,23 | 14 k USD |
| 2023-12-26 | Eisele Jeffrey | Chief Development Officer | Sell | 68 | 57,86 | 4 k USD |
| 2023-12-26 | Eisele Jeffrey | Chief Development Officer | Sell | 68 | 57,86 | 4 k USD |
| 2023-12-19 | Watson David O. | General Counsel | Buy | 8 k | 13,85 | 109 k USD |
| 2023-12-19 | Watson David O. | General Counsel | Sell | 2 k | 57,00 | 91 k USD |
| 2023-12-19 | Watson David O. | General Counsel | Sell | 2 k | 57,38 | 132 k USD |
| 2023-12-19 | Watson David O. | General Counsel | Buy | 8 k | 13,85 | 109 k USD |
| 2023-12-19 | Watson David O. | General Counsel | Sell | 2 k | 57,00 | 91 k USD |
| 2023-12-19 | Watson David O. | General Counsel | Sell | 2 k | 57,38 | 132 k USD |
| 2023-12-14 | Dunlop A. Sinclair | Director | Buy | 6 k | 13,19 | 83 k USD |
| 2023-12-14 | Dunlop A. Sinclair | Director | Buy | 6 k | 13,19 | 83 k USD |
| 2023-11-30 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 14 k | 10,03 | 142 k USD |
| 2023-11-30 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 14 k | 54,73 | 758 k USD |
| 2023-11-30 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 300 | 54,79 | 16 k USD |
| 2023-11-30 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 14 k | 10,03 | 142 k USD |
| 2023-11-30 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 14 k | 54,73 | 758 k USD |
| 2023-11-30 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 300 | 54,79 | 16 k USD |
| 2023-11-21 | Francois Cedric | Chief Executive Officer | Sell | 5 k | 48,80 | 244 k USD |
| 2023-11-21 | Francois Cedric | Chief Executive Officer | Sell | 5 k | 48,80 | 244 k USD |
| 2023-11-17 | Dunlop A. Sinclair | Director | Sell | 9 k | 49,99 | 445 k USD |
| 2023-11-17 | Dunlop A. Sinclair | Director | Sell | 9 k | 49,99 | 445 k USD |
| 2023-11-17 | Machiels Alec | Director | Buy | 1 k | 2,67 | 3 k USD |
| 2023-11-17 | Machiels Alec | Director | Sell | 1 k | 47,74 | 60 k USD |
| 2023-11-17 | Machiels Alec | Director | Buy | 1 k | 2,67 | 3 k USD |
| 2023-11-17 | Machiels Alec | Director | Sell | 1 k | 47,74 | 60 k USD |
| 2023-11-14 | Deschatelets Pascal | Chief Scientific Officer | Buy | 45 k | 3,76 | 169 k USD |
| 2023-11-14 | Deschatelets Pascal | Chief Scientific Officer | Buy | 45 k | 3,76 | 169 k USD |
| 2023-11-08 | Deschatelets Pascal | Chief Scientific Officer | Buy | 17 k | 2,67 | 47 k USD |
| 2023-11-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 12 k | 47,27 | 567 k USD |
| 2023-11-08 | Deschatelets Pascal | Chief Scientific Officer | Buy | 17 k | 2,67 | 47 k USD |
| 2023-11-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 12 k | 47,27 | 567 k USD |
| 2023-10-23 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 131 | 46,04 | 6 k USD |
| 2023-10-23 | Chopas James George | VP/Chief Accounting Officer | Sell | 132 | 46,04 | 6 k USD |
| 2023-10-23 | Chopas James George | VP/Chief Accounting Officer | Sell | 132 | 46,04 | 6 k USD |
| 2023-10-23 | DeLong Mark Jeffrey | Chief Business & Strat Officer | Sell | 131 | 46,04 | 6 k USD |
| 2023-10-17 | Dunlop A. Sinclair | Director | Sell | 24 k | 49,00 | 1.2 mn USD |
| 2023-10-17 | Dunlop A. Sinclair | Director | Sell | 24 k | 49,00 | 1.2 mn USD |
| 2023-10-17 | Machiels Alec | Director | Buy | 1 k | 2,67 | 3 k USD |
| 2023-10-17 | Machiels Alec | Director | Sell | 1 k | 48,50 | 61 k USD |
| 2023-10-17 | Machiels Alec | Director | Buy | 1 k | 2,67 | 3 k USD |
| 2023-10-17 | Machiels Alec | Director | Sell | 1 k | 48,50 | 61 k USD |
| 2023-10-09 | Deschatelets Pascal | Chief Scientific Officer | Buy | 19 k | 2,67 | 49 k USD |
| 2023-10-09 | Deschatelets Pascal | Chief Scientific Officer | Sell | 12 k | 40,38 | 485 k USD |
| 2023-10-09 | Deschatelets Pascal | Chief Scientific Officer | Buy | 19 k | 2,67 | 49 k USD |
| 2023-10-09 | Deschatelets Pascal | Chief Scientific Officer | Sell | 12 k | 40,38 | 485 k USD |
| 2023-09-19 | Francois Cedric | Chief Executive Officer | Sell | 150 k | 0,00 | 0 USD |
| 2023-09-19 | Francois Cedric | Chief Executive Officer | Buy | 150 k | 0,00 | 0 USD |
| 2023-09-19 | Francois Cedric | Chief Executive Officer | Sell | 150 k | 0,00 | 0 USD |
| 2023-09-19 | Francois Cedric | Chief Executive Officer | Buy | 150 k | 0,00 | 0 USD |
| 2023-09-18 | Nicholson Nur | Chief Technical Officer | Buy | 10 k | 29,76 | 289 k USD |
| 2023-09-18 | Nicholson Nur | Chief Technical Officer | Sell | 10 k | 42,21 | 410 k USD |
| 2023-09-18 | Nicholson Nur | Chief Technical Officer | Sell | 11 k | 46,15 | 491 k USD |
| 2023-09-18 | Machiels Alec | Director | Buy | 1 k | 2,67 | 3 k USD |
| 2023-09-18 | Machiels Alec | Director | Sell | 1 k | 45,00 | 56 k USD |
| 2023-09-18 | Machiels Alec | Director | Buy | 1 k | 2,67 | 3 k USD |
| 2023-09-18 | Machiels Alec | Director | Sell | 1 k | 45,00 | 56 k USD |
| 2023-09-18 | Nicholson Nur | Chief Technical Officer | Buy | 10 k | 29,76 | 289 k USD |
| 2023-09-18 | Nicholson Nur | Chief Technical Officer | Sell | 10 k | 42,21 | 410 k USD |
| 2023-09-18 | Nicholson Nur | Chief Technical Officer | Sell | 11 k | 46,15 | 491 k USD |
| 2023-09-15 | Machiels Alec | Director | Buy | 1 k | 2,67 | 3 k USD |
| 2023-09-15 | Machiels Alec | Director | Sell | 1 k | 45,34 | 57 k USD |
| 2023-09-15 | Machiels Alec | Director | Buy | 1 k | 2,67 | 3 k USD |
| 2023-09-15 | Machiels Alec | Director | Sell | 1 k | 45,34 | 57 k USD |
| 2023-09-14 | Chopas James George | VP/Chief Accounting Officer | Buy | 3 k | 0,00 | 0 USD |
| 2023-09-14 | Chopas James George | VP/Chief Accounting Officer | Buy | 3 k | 0,00 | 0 USD |
| 2023-09-08 | Deschatelets Pascal | Chief Scientific Officer | Buy | 19 k | 2,67 | 49 k USD |
| 2023-09-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 12 k | 42,87 | 514 k USD |
| 2023-09-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 12 k | 42,87 | 514 k USD |
| 2023-09-08 | Deschatelets Pascal | Chief Scientific Officer | Buy | 19 k | 2,67 | 49 k USD |
| 2023-09-06 | SCHEIBLER LUKAS | Chief Research Officer | Sell | 2 k | 43,01 | 76 k USD |
| 2023-09-06 | SCHEIBLER LUKAS | Chief Research Officer | Sell | 2 k | 43,01 | 76 k USD |
| 2023-09-01 | Francois Cedric | Chief Executive Officer | Buy | 300 k | 2,67 | 801 k USD |
| 2023-09-01 | Francois Cedric | Chief Executive Officer | Sell | 140 k | 41,70 | 5.8 mn USD |
| 2023-09-01 | Francois Cedric | Chief Executive Officer | Sell | 10 k | 42,44 | 436 k USD |
| 2023-09-01 | Francois Cedric | Chief Executive Officer | Buy | 300 k | 2,67 | 801 k USD |
| 2023-09-01 | Francois Cedric | Chief Executive Officer | Sell | 140 k | 41,70 | 5.8 mn USD |
| 2023-09-01 | Francois Cedric | Chief Executive Officer | Sell | 10 k | 42,44 | 436 k USD |
| 2023-08-31 | Chopas James George | VP/Chief Accounting Officer | Sell | 551 | 41,23 | 23 k USD |
| 2023-08-31 | Chopas James George | VP/Chief Accounting Officer | Sell | 551 | 41,23 | 23 k USD |
| 2023-08-08 | Deschatelets Pascal | Chief Scientific Officer | Buy | 19 k | 2,67 | 49 k USD |
| 2023-08-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 12 k | 23,66 | 284 k USD |
| 2023-08-08 | Deschatelets Pascal | Chief Scientific Officer | Buy | 19 k | 2,67 | 49 k USD |
| 2023-08-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 12 k | 23,66 | 284 k USD |
| 2023-07-21 | Machiels Alec | Director | Buy | 50 k | 2,67 | 133 k USD |
| 2023-07-21 | Machiels Alec | Director | Buy | 50 k | 2,67 | 133 k USD |
| 2023-07-20 | Machiels Alec | Director | Buy | 50 k | 2,67 | 134 k USD |
| 2023-07-20 | Machiels Alec | Director | Buy | 50 k | 2,67 | 134 k USD |
| 2023-07-17 | Machiels Alec | Director | Buy | 1 k | 2,67 | 3 k USD |
| 2023-07-17 | Machiels Alec | Director | Sell | 1 k | 64,79 | 81 k USD |
| 2023-07-17 | Machiels Alec | Director | Buy | 1 k | 2,67 | 3 k USD |
| 2023-07-17 | Machiels Alec | Director | Sell | 1 k | 64,79 | 81 k USD |
| 2023-07-10 | Deschatelets Pascal | Chief Scientific Officer | Buy | 19 k | 2,67 | 49 k USD |
| 2023-07-10 | Deschatelets Pascal | Chief Scientific Officer | Sell | 12 k | 84,55 | 1.0 mn USD |
| 2023-07-10 | Deschatelets Pascal | Chief Scientific Officer | Buy | 19 k | 2,67 | 49 k USD |
| 2023-07-10 | Deschatelets Pascal | Chief Scientific Officer | Sell | 12 k | 84,55 | 1.0 mn USD |
| 2023-07-03 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 7 k | 10,03 | 68 k USD |
| 2023-07-03 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 3 k | 89,41 | 285 k USD |
| 2023-07-03 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 3 k | 90,42 | 297 k USD |
| 2023-07-03 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 300 | 91,10 | 27 k USD |
| 2023-07-03 | Watson David O. | General Counsel | Sell | 9 k | 89,98 | 766 k USD |
| 2023-07-03 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 7 k | 10,03 | 68 k USD |
| 2023-07-03 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 3 k | 89,41 | 285 k USD |
| 2023-07-03 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 3 k | 90,42 | 297 k USD |
| 2023-07-03 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 300 | 91,10 | 27 k USD |
| 2023-07-03 | Watson David O. | General Counsel | Sell | 9 k | 89,98 | 766 k USD |
| 2023-06-28 | Watson David O. | General Counsel | Sell | 13 k | 0,00 | 0 USD |
| 2023-06-28 | Watson David O. | General Counsel | Buy | 13 k | 0,00 | 0 USD |
| 2023-06-28 | Watson David O. | General Counsel | Sell | 13 k | 0,00 | 0 USD |
| 2023-06-28 | Watson David O. | General Counsel | Buy | 13 k | 0,00 | 0 USD |
| 2023-06-20 | Machiels Alec | Director | Buy | 1 k | 2,67 | 3 k USD |
| 2023-06-20 | Machiels Alec | Director | Sell | 1 k | 88,41 | 111 k USD |
| 2023-06-20 | Machiels Alec | Director | Buy | 1 k | 2,67 | 3 k USD |
| 2023-06-20 | Machiels Alec | Director | Sell | 1 k | 88,41 | 111 k USD |
| 2023-06-08 | Deschatelets Pascal | Chief Scientific Officer | Buy | 19 k | 2,67 | 49 k USD |
| 2023-06-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 12 k | 91,35 | 1.1 mn USD |
| 2023-06-08 | Deschatelets Pascal | Chief Scientific Officer | Buy | 19 k | 2,67 | 49 k USD |
| 2023-06-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 12 k | 91,35 | 1.1 mn USD |
| 2023-06-05 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 70 k | 10,03 | 700 k USD |
| 2023-06-05 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 2 k | 90,60 | 145 k USD |
| 2023-06-05 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 31 k | 87,79 | 2.7 mn USD |
| 2023-06-05 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 7 k | 88,36 | 624 k USD |
| 2023-06-05 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 31 k | 89,83 | 2.7 mn USD |
| 2023-06-05 | Sullivan Timothy Eugene | Chief Financial Officer | Buy | 70 k | 10,03 | 700 k USD |
| 2023-06-05 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 2 k | 90,60 | 145 k USD |
| 2023-06-05 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 31 k | 87,79 | 2.7 mn USD |
| 2023-06-05 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 7 k | 88,36 | 624 k USD |
| 2023-06-05 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | 31 k | 89,83 | 2.7 mn USD |
| 2023-06-01 | Lewis Karen | Chief People Officer | Buy | 5 k | 34,11 | 171 k USD |
| 2023-06-01 | Lewis Karen | Chief People Officer | Sell | 5 k | 86,00 | 430 k USD |
| 2023-06-01 | Lewis Karen | Chief People Officer | Buy | 5 k | 34,11 | 171 k USD |
| 2023-06-01 | Lewis Karen | Chief People Officer | Sell | 5 k | 86,00 | 430 k USD |
| 2023-05-24 | Francois Cedric | Chief Executive Officer | Sell | 20 k | 0,00 | 0 USD |
| 2023-05-24 | Francois Cedric | Chief Executive Officer | Buy | 20 k | 0,00 | 0 USD |
| 2023-05-24 | Francois Cedric | Chief Executive Officer | Sell | 20 k | 0,00 | 0 USD |
| 2023-05-24 | Francois Cedric | Chief Executive Officer | Buy | 20 k | 0,00 | 0 USD |
| 2023-05-17 | Francois Cedric | Chief Executive Officer | Buy | 20 k | 2,67 | 53 k USD |
| 2023-05-17 | Machiels Alec | Director | Buy | 1 k | 2,67 | 3 k USD |
| 2023-05-17 | Machiels Alec | Director | Sell | 1 k | 88,66 | 111 k USD |
| 2023-05-17 | Francois Cedric | Chief Executive Officer | Buy | 20 k | 2,67 | 53 k USD |
| 2023-05-17 | Machiels Alec | Director | Buy | 1 k | 2,67 | 3 k USD |
| 2023-05-17 | Machiels Alec | Director | Sell | 1 k | 88,66 | 111 k USD |
| 2023-05-16 | Francois Cedric | Chief Executive Officer | Buy | 30 k | 2,67 | 80 k USD |
| 2023-05-16 | Francois Cedric | Chief Executive Officer | Sell | 934 | 83,17 | 78 k USD |
| 2023-05-16 | Francois Cedric | Chief Executive Officer | Sell | 2 k | 83,85 | 151 k USD |
| 2023-05-16 | Francois Cedric | Chief Executive Officer | Sell | 15 k | 85,01 | 1.2 mn USD |
| 2023-05-16 | Francois Cedric | Chief Executive Officer | Sell | 3 k | 85,90 | 258 k USD |
| 2023-05-16 | Francois Cedric | Chief Executive Officer | Sell | 8 k | 87,02 | 655 k USD |
| 2023-05-16 | Francois Cedric | Chief Executive Officer | Sell | 2 k | 87,67 | 186 k USD |
| 2023-05-16 | Francois Cedric | Chief Executive Officer | Buy | 30 k | 2,67 | 80 k USD |
| 2023-05-16 | Francois Cedric | Chief Executive Officer | Sell | 934 | 83,17 | 78 k USD |
| 2023-05-16 | Francois Cedric | Chief Executive Officer | Sell | 2 k | 83,85 | 151 k USD |
| 2023-05-16 | Francois Cedric | Chief Executive Officer | Sell | 15 k | 85,01 | 1.2 mn USD |
| 2023-05-16 | Francois Cedric | Chief Executive Officer | Sell | 3 k | 85,90 | 258 k USD |
| 2023-05-16 | Francois Cedric | Chief Executive Officer | Sell | 8 k | 87,02 | 655 k USD |
| 2023-05-16 | Francois Cedric | Chief Executive Officer | Sell | 2 k | 87,67 | 186 k USD |
| 2023-05-08 | Deschatelets Pascal | Chief Scientific Officer | Buy | 19 k | 2,67 | 49 k USD |
| 2023-05-08 | Deschatelets Pascal | Chief Scientific Officer | Sell | 12 k | 92,39 | 1.1 mn USD |
| 2023-05-03 | Townsend Adam J. | Chief Commercial Officer | Buy | 5 k | 15,09 | 75 k USD |
| 2023-05-03 | Townsend Adam J. | Chief Commercial Officer | Sell | 5 k | 82,71 | 414 k USD |
| 2023-05-03 | Townsend Adam J. | Chief Commercial Officer | Buy | 5 k | 15,09 | 75 k USD |
| 2023-05-03 | Townsend Adam J. | Chief Commercial Officer | Sell | 5 k | 82,71 | 414 k USD |